logo

ABSI

Absci
--
--(--)
Market Open: --
--
--(--)
Post-Market: --

ABSI Profile

Absci Corporation

A drug and target discovery company that harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins

Biological Technology
Invalid Date
07/22/2021
NASDAQ Stock Exchange
157
12-31
Common stock
18105 SE Mill Plain Blvd, Vancouver, WA 98683
--
Absci Corporation was incorporated as a limited liability company in Oregon in August 2011. The company is a data-first generative AI drug creation company that combines AI with scalable wet laboratory technology to create better biologics for patients at a faster rate.